Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
Shares in the Irvine-based medical device company rose 29% to $23.64 and a $975 million market within the first three hours ...
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...
President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...
DURHAM, N.C.and SEATTLE, Jan. 28, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...
While some studies suggest probiotics may help you lose weight and belly fat, more research is needed on their effectiveness.
Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...
The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...
BECKLEY, W.Va. — Jury deliberations begin Wednesday morning in the murder trial of former Raleigh County pharmacist Natalie ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...